We have previously shown that genistein, a broad spectrum tyrosine kinase inhibitor, blocks both the 5HT-induced translocation of eGFP-PKC Apl II in isolated sensory neurons and reversal of synaptic depression [1]. The gene discussed is PRRT2; the disease is depressive symptom measurement.